UCLA's Jonsson Comprehensive Cancer Center : JCCC Member Directory

Avital Harari, M.D.

Specialty:

Endocrine surgery

General Information:

Gender:	Female
Language(s):	English, Hebrew, Spanish

Affiliation(s):

Assistant Professor of Surgery, Department of Surgery

Member, JCCC Patients and Survivors Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Santa Monica-UCLA Medical Center and Orthopaedic Hospital

Education:

Fellowship:	Endocrine Surgery, UCSF/Mount Zion Medical Center, 2009 - 2010
Residency:	Surgery, New York-Presbyterian/Columbia University Medical Center, 2005 - 2009
Internship:	Surgery, New York-Presbyterian/Columbia University Medical Center, 2004 - 2005
Medical Degree:	M.D., Washington University School of Medicine, 2004

Certification(s):

Medical Board Certification(s):	Surgery, American Board of Surgery, 2010

Contact Information:

Phone:	(310) 206-0585
Email:	aharari@mednet.ucla.edu
Website:	http://endocrinesurgery.ucla.edu

Practice Information:

Clinical Interest(s):	Endocrine tumors (tumors of the adrenal, thyroid and parathyroid glands) Neuroendocrine tumors of the pancreas Solid tumors Thyroid

Scientific Interest(s):

Dr. Avital Harari is interested in translational and outcomes studies of patients with benign and malignant tumors of the adrenal, thyroid, and parathyroid glands, as well as the neuroendocrine pancreas and familial endocrine disorders (such as multiple endocrine neoplasia).

Selected Cancer-Related Publications:

Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012 Mar;13(1):11-23.

Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, Shen W, Gosnell J, Duh QY, Clark O. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011 Dec;96(12):3679-86. Epub 2011 Sep 21.

Harari A, Inabnet WB 3rd. Malignant pheochromocytoma: a review. Am J Surg. 2011 May;201(5):700-8. Epub 2010 Sep 27.

Harari A, Mitmaker E, Grogan RH, Lee J, Shen W, Gosnell J, Clark O, Duh QY. Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs). Ann Surg Oncol. 2011 Jun;18(6):1717-22. Epub 2011 Jan 5.

Harari A, Zarnegar R, Lee J, Kazam E, Inabnet WB 3rd, Fahey TJ 3rd. Computed tomography can guide focused exploration in select patients with primary hyperparathyroidism and negative sestamibi scanning. Surgery. 2008 Dec;144(6):970-6; discussion 976-9.